+ All Categories

Hocm mpuh

Date post: 04-Jul-2015
Category:
Upload: drnilesh-parikh
View: 1,055 times
Download: 0 times
Share this document with a friend
Description:
THIS IS CASE REPORT OF HOCM PATIENT,WHICH WAS FOR ORTHO.SURGERY. ANAESTHESIA CONDUCTED SUCCESSFULLY.
43
Dr. Nilesh Parikh MD,PDCC (Card.Anaes) Consultant Anaesthesiologist NADIAD Anaesthesia for HOCM patient
Transcript
Page 1: Hocm mpuh

Dr. Nilesh ParikhMD,PDCC

(Card.Anaes)

Consultant Anaesthesiologist

NADIAD

Anaesthesia for HOCM patient

Page 2: Hocm mpuh

Hypertrophic Obstructive Cardiomyopathy

Dr. Nilesh Parikh

Page 3: Hocm mpuh

Here is a patient named Kamlaben B Patel 85 yrs. Old,having # N/F, requring DHS Surgery.pt. is a known case of HTN Since 15 yrs. and she is taking Tab Amlodepine-Atenolol combination. Patient has been investigated and diagnosed to have HOCM by 2D ECHO., how would you proceed for this case?

Page 4: Hocm mpuh

Hypertrophic obstructive cardiomyopathy

Overview

• Background

• Pathophysiology

• Clinical picture

• Diagnosis

• Treatment

• Anesthetic consideration

4

Page 5: Hocm mpuh

Hypertrophic Obstructive CardioMyopathy (HOCM) is a rare genetic disorder characterized by left ventricular outflow tract (LVOT) obstruction. Clinical presentation ranges from absence of symptoms to sudden death. These patients presents considerable challenges and requires maintenance of desired hemodynamic parameters and management of specific complications. Factors like Tachycardia, Hypovolemia, Vasodilation andincreased cardiac contractility leads to exacerbation of the obstruction. Decrease in venous return and SVR or increase in myocardial contractility worsens the LVOT obstruction. These patients are highly prone to arrhythmias like AF & VT Management of anesthesia in these patients poses considerable challenges for the anesthesiologist.

Page 6: Hocm mpuh

Background

Prevalence of HCM: 1:500 to 1:1000 individuals ○ This occurrence is higher than previously thought, suggesting

a large number of affected but undiagnosed people

Men affected by almost 2:1 ratio over women

Global disease with most cases reported from USA, Canada, Western Europe, Israel, & Asia

Most common cause of SCD, age < 40 yr

Most common cause of SCD, in competitive

athletes

Page 7: Hocm mpuh

Normal Anatomy

7

Page 8: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

8

Page 9: Hocm mpuh

Hypertrophic cardiomyopathy (HOCM)

9

Page 10: Hocm mpuh

Pathophysiology of HOCM

Involves 4 interrelated processes:

– Left ventricular outflow obstruction

–Diastolic dysfunction

–Myocardial ischemia

–Mitral regurgitation

Page 11: Hocm mpuh

Pathophysiology

• Hypertrophy: in any region of left ventricle

• SAM: systolic anterior motion of anterior MV leaflet against hypertrophic septum (Bernoulli effect)

dynamic pressure gradient across LV outflow tract

midsystolic intraventricular obstruction of the flow

• SAM - Septal Contact dynamic obstruction increased by:

afterload

preload

contractility

11

Page 12: Hocm mpuh

• Diastolic Dysfunction

- Due to prolongation of isovolumic relaxation time (AV closure to MV opening)

- LV filling pressure

- Ventricular volume

- Atrial contribution to ventricular filling ~ 75%

• Poor Compliance

- LVEDP for any LVEDV

- CPP gradient

- Subendocardial ischemia12

Pathophysiology

Page 13: Hocm mpuh

Symptoms:

Dyspnea on exertion (90%)

- Reduced diastolic relaxation & LV filling

Angina (70-80%) - Inadequate myocardial perfusion

Syncope (20%) - Vasovagal attack/ transient arrhythmias

Palpitation (10%) - AF

- Loss of atrial contribution in LV filling

- Rapid rate

- 50 % pts of AF manifests as systemic embolisation

Page 14: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

• Lab studies:

– Blood test: non specific

– Genetic testing: for high risk group

• ECG:

– ST-T wave abnormalities

– LV hypertrophy, LA enlargement

– Axis deviation (left > right)

– Conduction abnormalities (P-R prolongation, BBB)

– A-fib (poor prognostic sign) 14

Page 15: Hocm mpuh

Electrocardiogram

LV strain pattern

LBBB/ RBBB / Lt ant hemiblock

Page 16: Hocm mpuh

ECG

Page 17: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

• Two - Dimensional Echocardiography and Doppler

• MR and Mitral prolapse

• Flow velocity: > 4.0 m/s

• LV outflow gradient: > 50 mm Hg

• EF : high to normal

• Small LV cavity

• Left atrial enlargement

• Septal thickness: 4-6 mm thicker than normal

• The hallmarks:

– SAM of Mitral valve

– Asymmetric septal hypertrophy17

Page 18: Hocm mpuh

X ray

Cardiomegaly

LA enlargement

Small aorta

Pulmonary edema

Page 19: Hocm mpuh

CXRHOCM

19

Cardiac enlargement > 1/2 thoracic width

Page 20: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

• Goals:

– Ventricular contractility

» Myocardial depression

– Ventricular volume

» Volume loading

– Ventricular compliance and outflow tract dimensions

– Pressure gradient across the LVOT

– Vasoconstriction

20

Page 21: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Medications

• Beta-Blockers: (Metoprolol, Propranolol, Atenolol, Sotalol )

• Calcium Channel blockers: (Verapamil)

• Antiarrhythmic: amiodarone and disopyramide

• Antitussives: avoid coughing

21

Page 22: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Beta - blockers

Pressure gradient across LVOT

– Inotropic state of left ventricle.

– Diastolic dysfunction

– Lt. Ventricle compliance

HR

–Myocardial oxygen consumption

–Myocardial ischemia potential

22

Page 23: Hocm mpuh

Calcium Channel Blockers:

Verapamil

Improves symptoms and exercise capacity (patients without marked obstruction to LV outflow)

Beneficial effect on ventricular relaxation and filling

Better angina control than BB

Hemodynamic deterioration with CCB agents - lowering of the afterload in the presence of severe outflow tract gradients and high diastolic filling pressures

Page 24: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Antiarrhythmics

• Amiodarone (Cordarone)

To date,

Only one pharmacological agent, has been shown to reduce the incidence of arrhythmogenic sudden cardiac death

24

Page 25: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Contraindication

• Inotropic

• Sympathomimetic

• Nitrates

• Except in patients with CAD

• Digitalis

• Except with uncontrolled A-fib.

• Diuretics

• Preload and ventricular volume

• Outflow gradient

25

Page 26: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Anesthetic considerations Pre-operative period

• Pre-medication– Avoid anxiety producing tachycardia

• -blocker and/or Ca++ channel blocker– Continue untill the day of surgery and postoperative

• Avoid arrhythmia– Aggressive treatment of arrhythmia

• Antiarrhythmic Meds

• Cardioversion

• Maintain adequate intravascular volume and preload

26

Page 27: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Anesthetic considerations

Inhalation Anesthetics

• Negative inotropy

• Decrease SAM-Septal contact

• Ideal for dose dependant myocardial depression

(Halothane > Enflurane > Isoflurane > Desflurane, Sevoflurane)

• Avoid hypotension due to underlying hypovolemia

27

Page 28: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Anesthetic considerations

Regional anesthesia

• Relatively contraindicated

• Spinal should be avoided

• Epidural can be given

• Avoid bolus administration

• Avoid hypotension

• Replace intravascular volume

• Use Vasopressors like noradrenalineand phenylephrine

28

Page 29: Hocm mpuh

Hypertophic cardiomyopathy (HOCM)

Anesthetic considerations

IV Vasopressors

• Phenylepherine /Noradrenaline

– Low risk / high yield choice for hypotension

–Augment perfusion and CPP

–Decrease pressure gradient

– Increase vagal reflex

29

Page 30: Hocm mpuh

Hypertrophic cardiomyopathy (HOCM)

Anesthetic considerations

• MR with HOCM

Inotropes and Vasodilators worsen ventricular ejection

Vasoconstrictors improve ventricular ejection

30

Page 31: Hocm mpuh

Here is a patient named Kamlaben B Patel 85 yrs. Old,having # N/F, requring DHS Surgery.pt. is a known case of HTN Since 15 yrs. and she is taking Tab Amlodepine-Atenolol combination. Patient has been investigated and diagnosed to have HOCM by 2D ECHO., how would you proceed for this case?

Page 32: Hocm mpuh
Page 33: Hocm mpuh
Page 34: Hocm mpuh
Page 35: Hocm mpuh
Page 36: Hocm mpuh
Page 37: Hocm mpuh
Page 38: Hocm mpuh
Page 39: Hocm mpuh

What would we the choice of Anaesthesia?

? Spinal? Epidural? General anaesthesia

Page 40: Hocm mpuh

I planned Epidural for this patient.Pt.taken in OT. Venous access with two peripheral lines. Oxygen started and connected with monitor. First dose inj.xylocaine 2% 15 cc given. Sooner after this dose, inj. Noradrenaline infusion started @

1ml/hr.(4mg/50cc)It was incresed to 2ml/hr.as per need. (dose of Norad. is 0.04-0.4 mcg/kg/min) IV fluids inj.Hydrxyethyl starch 500 ml and one unit of Blood. Oxygen @3-4 lit/min given continuously. inj.Antibiotic, patoprazole, ondansetron given. Second dose of Epidural inj.Bupivacaine 3 cc given. Patient remained stable intra and post op. Shifed to ICU ,Where oxygen continued with monitoring. Patient’s vitals were as follow:

Page 41: Hocm mpuh

TIME HEARTRATE

SYSTOLICBP

DIASTOLICBP

SPO2%

8:28 am 56 153 58 93

8:33 54 154 58 99

9:10 58 116 42 98

9:23 57 107 38 98

9:33 53 111 39 98

9:43 52 108 39 99

9:53 54 129 40 99

10:03 54 148 44 100

10:13 55 158 45 100

10:23 54 156 45 99

11:30 55 158 50 99

Vital parameters of patient : HOCM-DHS 10/1/2013

Page 42: Hocm mpuh

Comments: Any patient with HTN and ECG changes always get cardiac evaluation done.

Patients with HOCM ,presenting for surgery where regional anaes. is preferred,Always maintain Hemodynamics with vasopressors and fluids. Don’t give any Inotropic or chronotropic agents.

Keep Defibrillator available ,as pts. are highly prone for Arrythmias.

Pt’s preload should be maintained adequetely.

Page 43: Hocm mpuh

Thank you

spinal

EPIDURAL

G/A TAKE CARE OF ME

Message:


Recommended